Delivery Order SPE2DB20D2002-SPE2DB25FL72Q
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,606.25 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities, with performance completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,496.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 2, 2025, with a contract value of $1,235.98 and completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $29,137.90 delivery order on August 28, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,915.46 under a firm fixed price contract. This delivery order, which is expected to be completed by September 5, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,359.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units. The contract carries a firm fixed price and is classified as a child order under a larger vehicle, with an ultimate completion date of September 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not issued under a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units). This competitively awarded, firm fixed-price contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The product will be delivered to the AmerisourceBergen corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.16 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL72QDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,576.62 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on September 2, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is classified as a child contract under a larger vehicle. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Trulicity, a diabetes medication, represents one of the specialty pharmaceutical products available through this contract vehicle, which also encompasses brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/2/25 |